# Ajay Devgn challenges FDA show-cause notice over Vimal Elaichi ad 2026-10-30T17:38:10+00:00 | Governance | Indian Opinion Desk Corroboration: 2 independent outlets Bollywood actor Ajay Devgn has moved the Bombay High Court challenging a show-cause notice from the Maharashtra Food and Drugs Administration over his appearance in advertisements for ‘Vimal Elaichi’, which the FDA alleges is surrogate promotion for banned pan masala. The petition is likely to be heard by a division bench of Chief Justice Mahesh C Tripathi and Justice Advait Sethna on November 4. ## Indian Opinion Analysis Both sources report the same facts but differ in their focus. Barandbench.com leads with Ajay Devgn's legal challenge, detailing his petition's arguments and the earlier Delhi High Court ruling, while Economic Times leads with the FDA chief announcing that proceedings against the trio are complete and the matter is moving to adjudication. The barandbench.com account omits the FDA chief's statement that adjudication will proceed irrespective of Devgn's petition, whereas Economic Times includes that assertion. The coverage is uniform in reporting the core dispute: surrogate advertising for Vimal Pan Masala. The key open point is the November 4 hearing before the Bombay High Court and the FDA's planned adjudication referral by next week. ## Coverage Coverage: 2 sources, 2 neutral - barandbench.com (neutral report) Focuses on legal challenge, omits FDA chief's comment that proceedings continue regardless. - economictimes.indiatimes.com (neutral report) Leads with FDA chief's announcement that investigation complete, adjudication next. This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Tags: Ajay Devgn, Bombay High Court, Maharashtra FDA, Shah Rukh Khan, Tukaram Mundhe, Vimal Elaichi Canonical: https://indianopinion.org/ajay-devgn-challenges-fda-show-cause-notice-over-vimal-elaichi-ad/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/ajay-devgn-challenges-fda-show-cause-notice-over-vimal-elaichi-ad/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/